Rachel Mary Thomson

Desensitisation protocol for ethambutol in the treatment of Mycobacterium avium complex pulmonary disease

Abstract Background Ethambutol is a key component of treatment for Mycobacterium avium complex pulmonary disease (MAC-PD), primarily through suppression of macrolide resistance. However, adverse drug reactions frequently lead to treatment interruption, and evidence-based alternat...